OptiBiotix Health Plc (OPTBF)

0.11 0.00 (0.00%) USD  |  OTCM  |  Jul 23, 16:00
More

OptiBiotix Health PE Ratio

PE Ratio Chart

View PE Ratio for OPTBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PE Ratio Chart
Start Trial

Historical PE Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 29, 2022 0.0099
June 28, 2022 0.0099
June 27, 2022 0.0099
June 24, 2022 0.0099
June 23, 2022 0.0099
June 22, 2022 0.0099
June 21, 2022 0.0099
June 17, 2022 0.0099
June 16, 2022 0.0099
June 15, 2022 0.0099
June 14, 2022 0.0099
June 13, 2022 0.0099
June 10, 2022 0.0099
June 09, 2022 0.0099
June 08, 2022 0.0099
June 07, 2022 0.0099
June 06, 2022 0.0099
June 03, 2022 0.0099
June 02, 2022 0.0099
June 01, 2022 0.0099
May 31, 2022 0.0099
May 27, 2022 0.0099
May 26, 2022 0.0099
May 25, 2022 0.0099
May 24, 2022 0.0099
Date Value
May 23, 2022 0.0099
May 20, 2022 0.0099
May 19, 2022 0.0099
May 18, 2022 0.0099
May 17, 2022 0.0099
May 16, 2022 0.0099
May 13, 2022 0.0099
May 12, 2022 0.0099
May 11, 2022 0.0099
May 10, 2022 0.0099
May 09, 2022 0.0099
May 06, 2022 0.0099
May 05, 2022 0.0099
May 04, 2022 0.0099
May 03, 2022 0.0099
May 02, 2022 0.0099
April 29, 2022 0.0099
April 28, 2022 0.0099
April 27, 2022 0.0099
April 26, 2022 0.0099
April 25, 2022 0.0099
April 22, 2022 0.0099
April 21, 2022 0.0099
April 20, 2022 0.0099
April 19, 2022 0.0099

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

View PE Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

View PE Ratio Benchmarks
Start Trial
Kiniksa Pharmaceuticals International Plc 69.28
Autolus Therapeutics Plc --
Barinthus Biotherapeutics Plc --
Scancell Holdings Plc --
Adaptimmune Therapeutics Plc --

PE Ratio Related Metrics

PS Ratio 7.356
PEG Ratio -0.029
Price 0.11
Earnings Yield -45.55%
Market Cap 11.36M
PEGY Ratio -0.029